SFlt-1/PlGF ratio as a prognostic marker of adverse outcomes in women with early-onset preeclampsia

Pregnancy Hypertension

Volumn 3, Issue 3, 2013, Pages 191-195

  De Oliveira, Leandro ^a,b   Peraçoli, José C ^c   Peraçoli, Maria T ^c   Korkes, Henri ^a,b   Zampieri, Giafranco ^d   Moron, Antonio F ^a   Sass, Nelson ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Hospital e Maternidade Vila Nova Cachoeirinha   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^d Laboratory of Clinical Pathology Salomão and Zoppi   (Brazil)

Author keywords

Inflammation; PlGF; Preeclampsia; sFlt 1

Indexed keywords

PLACENTAL GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; BRAZIL; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

EID: 84878870151     PISSN: 22107789     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.preghy.2013.02.003     Document Type: Article

References (15)

1. A.B. Wallis, A.F. Saftlas, J. Hsia, and H.K. Atrash Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004 Am J Hypertens 21 2008 521 526
2. R. Pijnenborg, G. Dixon, W.B. Robertson, and I. Brosens Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy Placenta 1 1980 3 19
3. G.J. Burton, D.S. Charnock-Jones, and E. Jauniaux Regulation of vascular growth and function in the human placenta Reproduction 138 6 2009 895 902
4. C.W. Redman, and I.L. Sargent Circulating microparticles in normal pregnancy and pre-eclampsia Placenta 29 Suppl. A 2008 S73 S77
5. A. Wang, S. Rana, and S.A. Karumanchi The role of angiogenic factors in its pathogenesis Physiology 24 2009 147 158
6. R.L. Kendall, and K.A. Thomas Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor Proc Natl Acad Sci USA 90 1993 10705 10709
7. ACOG practice bulletin Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002 Obstet Gynecol 99 2002 159 167
8. R.J. Levine, S.E. Maynard, C. Qian, K.H. Lim, L.J. England, and K.F. Yu Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 2004 672 683
9. T. Chaiworapongsa, R. Romero, Y.M. Kim, G.J. Kim, M.R. Kim, and J. Espinoza Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia J Matern Fetal Neonatal Med 17 2005 3 18
10. S. Sunderji, E. Gaziano, D. Wothe, L.C. Rogers, B. Sibai, and S.A. Karumanchi Automated assays for sVEGF R1 and PIGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study Am J Obstet Gynecol 202 2010 40 [e41-e47]
11. S. Rana, C.E. Powe, S. Salahuddin, S. Verlohren, F.H. Perschel, and R.J. Levine Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia Circulation 125 7 2012 911 919
12. P. von Dadelszen, J.M. Menzies, B. Payne, and L.A. Magee PIERS (Pre-eclampsia Integrated Estimate of RiSk) study group. Predicting adverse outcomes in women with severe pre-eclampsia Semin Perinatol 33 3 2009 152 157
13. P. von Dadelszen, B. Payne, J. Li, J.M. Ansermino, F. Broughton Pipkin, and A.M. Cote Prediction of adverse maternal outcomes in preeclampsia: development and validation of the fullPIERS model Lancet 377 2011 219 227
14. C.M. Koopmans, J.J. Zwart, H. Groen, K.W. Bloemenkamp, B.W. Mol, and M.G. Van Pampus Risk indicators for eclampsia in gestational hypertension or mild preeclampsia at term Hypertens Pregnancy 30 4 2011 433 446
15. S. Verlohren, I. Herraiz, O. Lapaire, D. Schlembach, M. Moertl, and H. Zeisler The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients Am J Obstet Gynecol 206 1 2012 [58.e1-58.e8]